Breast Cancer Market Research Reports

Your Breast Cancer Market guide including research reports, industry analysis, market forecasts, market share, size and other info. Covers, breast cancer drugs, therapies and more.
RSS Sort By :
TITLE Price Buy Now More options

According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing ...

$ 5650


Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carc...

$ 3000


Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carc...

$ 3000


PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuse...

$ 10995


HER2-Negative Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current...

$ 4995


HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the curren...

$ 6995


HER2-Negative Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the curr...

$ 4995


HER2-Negative Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the curr...

$ 4995


HER2-Negative Breast Cancer - Current and Future Players Summary GlobalData has released its pharma report, “HER2-Negative Breast Cancer - Current and Future Players”. The report is a vital source of up-to-date information w...

$ 2995


Global Markets Direct's, ?Breast Cancer - Pipeline Review, H1 2015', provides an overview of the Breast Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Breast Cance...

$ 2500


Global Markets Direct's, ?Metastatic Breast Cancer Pipeline Review, H2 2014', provides an overview of the Metastatic Breast Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic developm...

$ 2000


Global Markets Direct's, ?Breast Cancer Pipeline Review, H2 2014', provides an overview of the Breast Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Breast Cancer,...

$ 2500


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 6995


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 4995


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 4995


HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER...

$ 4995


GlobalData has released its new PharmaPoint Drug Evaluation report, "Herceptin (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023". HER2-positive breast cancer is the second most common cancer in the world and the most co...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Perjeta (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023". HER2-positive breast cancer is the second most common cancer in the world and the most comm...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Kadcyla (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023". HER2-positive breast cancer is the second most common cancer in the world and the most comm...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, "Tykerb (HER2-Positive Breast Cancer) Forecast and Market Analysis to 2023". HER2-positive breast cancer is the second most common cancer in the world and the most commo...

$ 3495

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: